Chelsea McLean

Generating author description...

All published works

Action	Title	Year	Authors
+	Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases	2024	Aurélie Wiedemann Édouard Lhomme Mélanie Huchon Emile Foucat Marion Bérerd-Camara Lydia Guillaumat Marcel Yaradouno Jacqueline Tambalou Cécile Rodrigues Alexandre Lima de Araújo Ribeiro
+	Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised, phase 2 trial	2024	Ynke Larivière Trésor Zola Matuvanga Bernard Isekah Osang’ir Solange Milolo Rachel Meta Primo Kimbulu Cynthia Robinson Michael Katwere Chelsea McLean Gwen Lemey
+ PDF Chat	Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial	2024	Neil Goldstein Chelsea McLean Auguste Gaddah Joachim Doua Babajide Keshinro Linda Bus-Jacobs Jenny Hendriks Kerstin Lühn Cynthia Robinson Macaya Douoguih
+ PDF Chat	Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans	2023	Chelsea McLean Karin Dijkman Auguste Gaddah Babajide Keshinro Michael Katwere Macaya Douoguih Cynthia Robinson Laura Solforosi Dominika N. Czapska-Casey Liesbeth Dekking
+ PDF Chat	Randomized Trial of Vaccines for Zaire Ebola Virus Disease	2022	Mark Kieh Laura Richert Abdoul Habib Béavogui Birgit Grund Bailah Leigh Éric D’Ortenzio Seydou Doumbia Edouard Lhomme Samba O. Sow Renaud Vatrinet

Common Coauthors

Coauthor	Papers Together
Cynthia Robinson	4
Babajide Keshinro	3
Auguste Gaddah	3
Jenny Hendriks	3
Macaya Douoguih	3
Aurélie Wiedemann	2
Alpha Diallo	2
Abdoul Habib Béavogui	2
James D. Neaton	2
Geneviève Chêne	2
Sylvain Landry Faye	2
Céline Roy	2
Jakub K. Simon	2
Mohamed Samai	2
Jérôme Pierson	2
Renaud Vatrinet	2
Bonnie Dighero-Kemp	2
Samba O. Sow	2
Stephen B. Kennedy	2
Gibrilla F. Deen	2
Niouma Pascal Millimouno	2
Mark Kieh	2
Deborah Watson-Jones	2
Éric D’Ortenzio	2
Michael Katwere	2
Shelley Lees	2
Laura Richert	2
Kerstin Lühn	2
Seydou Doumbia	2
Birgit Grund	2
Lisa E. Hensley	2
Alseny Modet Camara	2
Hélène Espérou	2
Tijili Tyee	1
Julia Lysander	1
Nelson Dozier	1
Richard Kojan	1
Jean‐Pierre Van Geertruyden	1
Yazdan Yazdanpanah	1
David Ishola	1
Beth Baseler	1
Sibiry Samake	1
Alain DuChêne	1
Teedoh Beyslow	1
Melissa E. Hughes	1
Bolarinde Lawal	1
John McCullough	1
Dickens Kowuor	1
Natasha Dubois Cauwelaert	1
Papa Ndiaga Cissé	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+ PDF Chat	Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans	2023	Chelsea McLean Karin Dijkman Auguste Gaddah Babajide Keshinro Michael Katwere Macaya Douoguih Cynthia Robinson Laura Solforosi Dominika N. Czapska-Casey Liesbeth Dekking	3
+ PDF Chat	Randomized Trial of Vaccines for Zaire Ebola Virus Disease	2022	Mark Kieh Laura Richert Abdoul Habib Béavogui Birgit Grund Bailah Leigh Éric D’Ortenzio Seydou Doumbia Edouard Lhomme Samba O. Sow Renaud Vatrinet	3
+ PDF Chat	Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins	2020	Till Koch Monika Rottstegge Paula Ruibal Sergio Gómez‐Medina Emily V. Nelson Beatriz Escudero-Pérez Matthias Pillny My Linh Ly Fara Raymond Koundouno Joseph Akoi Boré	2
+ PDF Chat	Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study	2017	D. Gray Heppner Tracy Kemp Brian K. Martin W. Jay Ramsey Richard Nichols Emily J. Dasen Charles J. Link Rituparna Das Zhi Jin Xu Eric Sheldon	1
+	Correlates of vaccine-induced protective immunity against Ebola virus disease	2018	Donata Medaglini Francesco Santoro Claire‐Anne Siegrist	1
+ PDF Chat	Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection	2019	Andrea Menicucci Allen Jankeel Heinz Feldmann Andrea Marzi Ilhem Messaoudi	1
+ PDF Chat	Long-lasting severe immune dysfunction in Ebola virus disease survivors	2020	Aurélie Wiedemann Emile Foucat Hakim Hocini Cécile Lefebvre Boris P. Hejblum Mélany Durand Miriam Krüger Alpha Kabinet Keïta Ahidjo Ayouba Stéphane Mély	1
+ PDF Chat	Understanding Long-term Evolution and Predictors of Sequelae of Ebola Virus Disease Survivors in Guinea: A 48-Month Prospective, Longitudinal Cohort Study (PostEboGui)	2021	Mamadou Saliou Kalifa Diallo Abdoulaye Touré Mamadou Sow Cécé Kpamou Alpha Kabinet Keïta Bernard Taverne Martine Peeters Philippe Msellati Thierno Alimou Barry Jean-François Étard	1
+ PDF Chat	Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study	2021	Mamadou Saliou Kalifa Diallo Ahidjo Ayouba Alpha Kabinet Keïta Guillaume Thaurignac Mamadou Sow Cécé Kpamou Thierno Alimou Barry Philippe Msellati Jean-François Étard Martine Peeters	1
+ PDF Chat	Ebola virus disease	2019	Denis Malvy Anita K. McElroy Hilde De Clerck Stephan Günther Johan van Griensven	1
+ PDF Chat	Ebola virus disease	2020	Shevin T. Jacob Ian Crozier William A. Fischer Angela Hewlett Colleen S. Kraft Marc-Antoine de La Vega Moses J Soka Victoria Wahl‐Jensen Anthony Griffiths Laura Bollinger	1
+ PDF Chat	Model-based evaluation of the impact of prophylactic vaccination applied to Ebola epidemics in Sierra Leone and Democratic Republic of Congo	2022	Ravi Potluri Amit Kumar Valérie Oriol-Mathieu Thierry Van Effelterre Laurent Metz Hitesh Bhandari	1
+	Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the Congo	2022	Marie Jaspard Sabue Mulangu Sylvain Juchet Béatrice Serra Ibrahim Dicko Hans-Joeg Lang Baweye Mayoum Baka Gaston Musemakweli Komanda Jeremie Muhindo Katsavara Patricia Kabuni	1
+	Targeted preventive vaccination campaigns to reduce Ebola outbreaks: An individual-based modeling study	2022	Donal Bisanzio Ashley E. Davis Sandra E. Talbird Thierry Van Effelterre Laurent Metz Maren Gaudig Valérie Oriol Mathieu Anita J. Brogan	1
+ PDF Chat	Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability	2023	Angela Huttner Sélidji Todagbé Agnandji Olivier Engler Jay W. Hooper Steve Kwilas Keersten M. Ricks Tamara L. Clements Hulda R. Jónsdóttir Sravya Sowdamini Nakka Sylvia Rothenberger	1
+ PDF Chat	The control of the false discovery rate in multiple testing under dependency	2001	Yoav Benjamini Daniel Yekutieli	1
+	Case fatality risk among individuals vaccinated with rVSVΔG-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo	2024	Rebecca M. Coulborn Mathieu Bastard Nicolas Peyraud Etienne Gignoux Francisco J. Luquero Bérengère Guai Stéphane Hans Bateyi Mustafa Elisabeth Mukamba Musenga Steve Ahuka‐Mundeke	1
+ PDF Chat	The cost of an Ebola case	2015	Sarah M. Bartsch Katrin M. Gorham Bruce Y. Lee	1
+ PDF Chat	Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea	2017	Fabien Subtil Charlotte Lanièce Delaunay Alpha Kabinet Keïta Mamadou Sow Abdoulaye Touré Sandrine Leroy Philippe Msellati N’Fally Magassouba Sylvain Baize Hervé Raoul	1